$2.60
-0.17 (-6.14%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where ACON is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 observational
Held by 1 tracked-famous manager (SUSQUEHANNA INTERNATIONAL GROUP, LLP) · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| Examination of Nociscan Impact on Discogenic Low Back Pain Surgical OutcomesNCT06661850observationalChange in back pain on 100mm Visual Analog Scale (VAS) Pain Assessment | — | Recruiting | Procedure: Fusion or TDR determined by investigator. | Discogenic Low Back Pain | 300 | 2027-09-30 | in 407 d | 2026-07-24 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19